Wallonia & Brussels against COVID-19 - Jean-Paul Deslypere, MD

Jean-Paul Deslypere, MD

Aesculape CRO Belgium BV
" Treatment of COVID 19 complications with antibodies "
Funding: partly public partly private
Contact : This email address is being protected from spambots. You need JavaScript enabled to view it. 0492 735931

Tags: Company, Fundamental Research in Life and Health Sciences, Tests & Diagnostics, Therapy & Care, Vaccines & prevention, Big data & E-Health, People & Society, Economics, Ethics & Law, Public Policy, Information & Communication, Epidemiology, Technology & devices, Anti-viral approaches, Complications and organ damages, Drugs, Treatments, Biomarkers, Aerosols, Health education, Immunology, Digital epidemiology, Logistics, Mobile telephony, Models en Big data, Tele-medicine, Education and training, Ethics, Health policy, Public Information, Risk Management, Populations at risk, Transmission, Company en Fundamental Research, Company en Tests & Diagnostics, Company en Therapy & Care, Company en Vaccines & prevention, Company en Big data & E-Health, Company en People & Society, Company en Economics, Ethics & Law, Company en Public policy, Company en Information & Communication

University

Jean-Paul Deslypere, MD